help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamata, T.
Right arrow Articles by McGeer, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamata, T.
Right arrow Articles by McGeer, P. L.

American Journal of Pathology, Vol 140, 691-707, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue

T Kawamata, H Akiyama, T Yamada and PL McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada.

Expression of proteins associated with immune function was investigated immunohistochemically in postmortem brain and spinal cord of patients with amyotrophic lateral sclerosis (ALS). Reactive microglia/macrophages displaying high levels of leukocyte common antigen (LCA), the immunoglobulin receptor Fc gamma R1, lymphocyte function associated molecule-1 (LFA-1), the complement receptors CR3 and CR4, the class II major histocompatibility complex molecules HLA- DR, HLA-DP and HLA-DQ and common determinants of the class I HLA-A,B,C complex were abundant in affected areas in ALS. These areas included the primary motor cortex, motor nuclei of the brain stem, the anterior horn of the spinal cord, and the full extent of the corticospinal tract. A significant number of T lymphocytes of the helper/inducer (CD4+) and cytotoxic/suppressor (CD8+) subtypes were observed marginating along the walls of capillaries and venules and extending into the parenchyma of affected areas. Clusters of complement activated oligodendroglia as well as degenerating neurites positive for C3d and C4d were frequently detected in ALS-affected areas. These data provide evidence of immune-effector changes in ALS. They are consistent with an autoimmune or slow virus theory of the disorder, but may reflect only secondary changes.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
G. Gowing, F. Dequen, G. Soucy, and J.-P. Julien
Absence of Tumor Necrosis Factor-{alpha} Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations.
J. Neurosci., November 1, 2006; 26(44): 11397 - 11402.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O'Neill, S. C. Fagan, and M. E. Cudkowicz
Neuroprotective agents for clinical trials in ALS: A systematic assessment.
Neurology, July 11, 2006; 67(1): 20 - 27.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Boillee, K. Yamanaka, C. S. Lobsiger, N. G. Copeland, N. A. Jenkins, G. Kassiotis, G. Kollias, and D. W. Cleveland
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia.
Science, June 2, 2006; 312(5778): 1389 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
P J Shaw
Molecular and cellular pathways of neurodegeneration in motor neurone disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1046 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. IGNACIO, D. H. MOORE, A. P. SMITH, and N. M. LEE
Effect of Neuroprotective Drugs on Gene Expression in G93A/SOD1 Mice
Ann. N.Y. Acad. Sci., August 1, 2005; 1053(1): 121 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Bellucci, A. J. Westwood, E. Ingram, F. Casamenti, M. Goedert, and M. G. Spillantini
Induction of Inflammatory Mediators and Microglial Activation in Mice Transgenic for Mutant Human P301S Tau Protein
Am. J. Pathol., November 1, 2004; 165(5): 1643 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. P. Simpson, Y. K. Henry, J. S. Henkel, R. G. Smith, and S. H. Appel
Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden
Neurology, May 25, 2004; 62(10): 1758 - 1765.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
W. Yang, M. M. Sopper, C. Leystra-Lantz, and M. J. Strong
Microtubule-associated tau protein positive neuronal and glial inclusions in ALS
Neurology, December 23, 2003; 61(12): 1766 - 1773.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
O. Lidman, M. Swanberg, L. Horvath, K. W. Broman, T. Olsson, and F. Piehl
Discrete Gene Loci Regulate Neurodegeneration, Lymphocyte Infiltration, and Major Histocompatibility Complex Class II Expression in the CNS
J. Neurosci., October 29, 2003; 23(30): 9817 - 9823.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. M. Clement, M. D. Nguyen, E. A. Roberts, M. L. Garcia, S. Boillee, M. Rule, A. P. McMahon, W. Doucette, D. Siwek, R. J. Ferrante, et al.
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Science, October 3, 2003; 302(5642): 113 - 117.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Jeyakumar, R. Thomas, E. Elliot-Smith, D. A. Smith, A. C. van der Spoel, A. d'Azzo, V. Hugh Perry, T. D. Butters, R. A. Dwek, and F. M. Platt
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis
Brain, April 1, 2003; 126(4): 974 - 987.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rostagno, T. Revesz, T. Lashley, Y. Tomidokoro, L. Magnotti, H. Braendgaard, G. Plant, M. Bojsen-Moller, J. Holton, B. Frangione, et al.
Complement Activation in Chromosome 13 Dementias. SIMILARITIES WITH ALZHEIMER'S DISEASE
J. Biol. Chem., December 13, 2002; 277(51): 49782 - 49790.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Yasojima, W. W. Tourtellotte, E. G. McGeer, and P. L. McGeer
Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy
Neurology, September 25, 2001; 57(6): 952 - 956.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Raivich, L. L. Jones, C. U. A. Kloss, A. Werner, H. Neumann, and G. W. Kreutzberg
Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration
J. Neurosci., August 1, 1998; 18(15): 5804 - 5816.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Neumann, T. Misgeld, K. Matsumuro, and H. Wekerle
Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor
PNAS, May 12, 1998; 95(10): 5779 - 5784.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Tafti, S. Nishino, M. S. Aldrich, W. Liao, W. C. Dement, and E. Mignot
Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model
J. Neurosci., August 1, 1996; 16(15): 4588 - 4595.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A.S. Wierzbicki, W. K. Engel, R. G. Smith, E. Stefani, and S. H. Appel
Antibodies to L-Type Calcium Channels in Amyotrophic Lateral Sclerosis
N. Engl. J. Med., May 6, 1993; 328(18): 1355 - 1357.
[Full Text]

Home page
 J. Cell Biol.Home page
J. Robertson, J.-M. Beaulieu, M. M. Doroudchi, H. D. Durham, J.-P. Julien, and W. E. Mushynski
Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-{alpha}
J. Cell Biol., October 15, 2001; 155(2): 217 - 226.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.